tirzepatide vs semaglutide differences comparison effectiveness We know about the growing popularity of and for their positive weight loss outcomes. But how do tirzepatide vs semaglutide comparison efficacy

The findings of a large US real-world cohort (n= 18,000) study, published in 2024, show that patients on tirzepatide were significantly more likely to achieve 5 %, 10 % and 15 % weight loss compared with semaglutide (HR 1.76, 2.54, 3.24, respectively), with a 12-month mean weight difference of -6.9% 8

Good candidates: Adults with obesity (BMI 30+) who have not responded to diet and exercise alone Adults with overweight (BMI 27+) and a related health condition Patients with type 2 diabetes seeking better blood sugar control alongside weight loss Who should avoid semaglutide: People with a personal or family history of medullary thyroid carcinoma (MTC) People with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Pregnant or breastfeeding women People with a history of pancreatitis (use with caution, discuss with your doctor) Anyone with severe gastrointestinal disease Always disclose your full medical history to your prescribing provider before starting

[3] The true incidence of musculoskeletal symptoms during Ozempic treatment is difficult to quantify

This is the entry-level and most affordable option